Core Viewpoint - uniQure (QURE) is anticipated to report a year-over-year increase in earnings driven by higher revenues in its upcoming quarterly results for September 2025 [1] Financial Expectations - The consensus estimate indicates a quarterly loss of $0.85 per share, reflecting a year-over-year change of +6.6% [3] - Expected revenues are projected at $6.93 million, representing a significant increase of 202.6% from the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised 4.79% higher in the last 30 days, indicating a positive reassessment by analysts [4] - The Most Accurate Estimate for uniQure is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +22.54% [12] Earnings Surprise Potential - A positive Earnings ESP reading suggests a strong likelihood of an earnings beat, especially when combined with a Zacks Rank of 3 [10][12] - Historically, uniQure has beaten consensus EPS estimates three out of the last four quarters, with a notable surprise of +22.47% in the last reported quarter [13][14] Industry Context - In comparison, Axsome Therapeutics (AXSM) is expected to report a loss of $0.85 per share for the same quarter, with revenues projected at $164.05 million, up 56.6% year-over-year [18][19] - Axsome's consensus EPS estimate has been revised 38.2% lower recently, resulting in a negative Earnings ESP of -14.93% [19][20]

Core Viewpoint - The market anticipates a year-over-year decline in Leidos' earnings despite an increase in revenues for the quarter ending September 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Leidos is expected to report earnings of $2.61 per share, reflecting a year-over-year decrease of 10.9%, while revenues are projected to be $4.27 billion, an increase of 1.8% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised 0.26% higher in the last 30 days, indicating a slight positive reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for Leidos is lower than the consensus estimate, resulting in an Earnings ESP of -2.30%, suggesting a bearish outlook from analysts [12]. Historical Performance - Leidos has consistently beaten consensus EPS estimates in the past four quarters, with a notable surprise of +22.05% in the last reported quarter [13][14]. Investment Considerations - Despite the historical performance, the current combination of a negative Earnings ESP and a Zacks Rank of 3 makes it challenging to predict an earnings beat for Leidos [12][17].

Core Viewpoint - The market anticipates a year-over-year decline in earnings for LGI Homes due to lower revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - LGI Homes is expected to report quarterly earnings of $1.02 per share, reflecting a year-over-year decrease of 65.4%, with revenues projected at $416.73 million, down 36.1% from the previous year [3]. - The consensus EPS estimate has been revised down by 9.77% over the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that the Most Accurate Estimate for LGI Homes is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -5.21% [12]. - The stock currently holds a Zacks Rank of 5, indicating a bearish outlook, making it challenging to predict an earnings beat [12]. Historical Performance - In the last reported quarter, LGI Homes exceeded expectations by delivering earnings of $1.36 per share against an expected $1.21, resulting in a surprise of +12.40% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates twice [14]. Conclusion - LGI Homes does not appear to be a strong candidate for an earnings beat, and investors should consider additional factors when evaluating the stock ahead of the earnings release [17].

Core Insights - Wall Street anticipates a year-over-year increase in earnings for Madrigal (MDGL) due to higher revenues, with a focus on how actual results compare to estimates [1][2] - The upcoming earnings report is expected to be released on November 4, and stock movement will depend on whether key numbers exceed or fall short of expectations [2] Financial Expectations - Madrigal is projected to report a quarterly loss of $1.99 per share, reflecting a year-over-year change of +59.6% [3] - Revenues are expected to reach $249.15 million, representing a significant increase of 300.8% from the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised 10.44% higher in the last 30 days, indicating a positive reassessment by analysts [4] - The Most Accurate Estimate for Madrigal is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +27.84% [12] Earnings Surprise Prediction - A positive Earnings ESP reading suggests a likely earnings beat, especially when combined with a Zacks Rank of 2 (Buy) [10][12] - Madrigal has a history of beating consensus EPS estimates, having done so in the last four quarters [14] Industry Context - Another company in the Zacks Medical - Drugs industry, BioCryst Pharmaceuticals (BCRX), is expected to post earnings of $0.07 per share, indicating a year-over-year change of +200% [18] - BioCryst's revenues are projected to be $161.15 million, up 37.6% from the previous year, with an Earnings ESP of +17.12% [19][20]

Core Viewpoint - Oportun Financial Corporation (OPRT) is expected to report a year-over-year increase in earnings despite lower revenues for the quarter ended September 2025, with the actual results being crucial for stock price movement [1][2]. Earnings Expectations - The consensus estimate for Oportun Financial's quarterly earnings is $0.26 per share, reflecting a significant year-over-year increase of +1200% [3]. - Revenues are projected to be $238.85 million, which is a decrease of 4.5% compared to the same quarter last year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised 3% lower, indicating a reassessment by analysts regarding the company's earnings prospects [4]. - The Most Accurate Estimate for Oportun Financial is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -13.73%, suggesting a bearish outlook from analysts [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the likelihood of actual earnings deviating from consensus estimates, with a positive reading being a strong predictor of an earnings beat [9][10]. - Oportun Financial currently holds a Zacks Rank of 3 (Hold), complicating predictions regarding an earnings beat [12]. Historical Performance - In the last reported quarter, Oportun Financial exceeded the expected earnings of $0.22 per share by delivering $0.31, resulting in a surprise of +40.91% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates three times [14]. Industry Comparison - Acadian Asset Management (AAMI), another player in the Zacks Financial - Miscellaneous Services industry, is expected to report earnings of $0.73 per share for the same quarter, representing a year-over-year change of +23.7% [18]. - AAMI's revenues are anticipated to be $145.62 million, up 18.3% from the previous year, with a recent EPS estimate revision of +5.1% [19].

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for SLR Investment due to lower revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - The upcoming earnings report is expected to show quarterly earnings of $0.41 per share, reflecting an 8.9% decrease year-over-year, and revenues of $55.69 million, down 6.8% from the previous year [3]. - The consensus EPS estimate has been revised down by 1.79% over the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that the Most Accurate Estimate for SLR Investment is lower than the consensus estimate, resulting in an Earnings ESP of -0.61%, indicating bearish sentiment among analysts [12]. - The stock currently holds a Zacks Rank of 4, complicating predictions of an earnings beat [12]. Historical Performance - In the last reported quarter, SLR Investment was expected to post earnings of $0.41 per share but delivered $0.40, resulting in a surprise of -2.44% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates twice [14]. Conclusion - SLR Investment does not appear to be a strong candidate for an earnings beat, and investors should consider additional factors when evaluating the stock ahead of the earnings release [17].

Core Viewpoint - The market anticipates a year-over-year decline in Supernus Pharmaceuticals' earnings despite an increase in revenues when the company reports its quarterly results for the period ending September 2025 [1][3]. Earnings Expectations - Supernus is expected to report earnings of $0.47 per share, reflecting a significant year-over-year decrease of 55.7%. Revenue is projected to be $182.06 million, which is a 3.6% increase compared to the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 14.29% higher in the last 30 days, indicating a reassessment by analysts of their initial estimates [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate matches the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%. This suggests no recent differing analyst views from the consensus [12]. Historical Performance - In the last reported quarter, Supernus exceeded the expected earnings of $0.47 per share by delivering $0.91, resulting in a surprise of +93.62%. The company has beaten consensus EPS estimates in all of the last four quarters [13][14]. Investment Considerations - Despite the positive historical performance, Supernus does not appear to be a strong candidate for an earnings beat this time. Investors are advised to consider other factors beyond earnings results when making investment decisions [15][17].

Core Viewpoint - Stanley Black & Decker (SWK) is anticipated to report a year-over-year decline in earnings despite an increase in revenues for the quarter ending September 2025, with the consensus outlook indicating a potential impact on the stock price based on actual results compared to estimates [1][2]. Earnings Expectations - The consensus estimate for Stanley Black & Decker's quarterly earnings is $1.19 per share, reflecting a year-over-year decrease of 2.5%, while revenues are projected to be $3.77 billion, representing a 0.5% increase from the previous year [3]. - The consensus EPS estimate has been revised 0.18% higher in the last 30 days, indicating a slight positive adjustment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP (Expected Surprise Prediction) model suggests that the Most Accurate Estimate for Stanley Black & Decker is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -0.95%, which indicates a bearish outlook from analysts [11]. - The stock currently holds a Zacks Rank of 3 (Hold), complicating predictions of an earnings beat [11]. Historical Performance - In the last reported quarter, Stanley Black & Decker exceeded the expected earnings of $0.38 per share by delivering $1.08, resulting in a surprise of +184.21% [12]. - Over the past four quarters, the company has successfully beaten consensus EPS estimates each time [13]. Industry Comparison - Lincoln Electric Holdings (LECO), a competitor in the Zacks Manufacturing - Tools & Related Products industry, is expected to report earnings of $2.39 per share for the same quarter, reflecting a year-over-year increase of 11.7%, with revenues projected at $1.04 billion, up 5.9% [17][18]. - Despite a recent EPS estimate revision of 1.5% higher for Lincoln Electric, it also has a negative Earnings ESP of -1.22%, combined with a Zacks Rank of 2 (Buy), making predictions of an earnings beat uncertain [18][19].

Core Viewpoint - Molson Coors Brewing (TAP) is anticipated to report a year-over-year decline in earnings due to lower revenues for the quarter ended September 2025, with the actual results being a significant factor influencing its near-term stock price [1][2]. Earnings Expectations - The consensus estimate for Molson Coors' quarterly earnings is $1.72 per share, reflecting a year-over-year decrease of 4.4%. Revenues are projected to be $3.03 billion, down 0.4% from the same quarter last year [3]. - The consensus EPS estimate has been revised down by 3.84% over the last 30 days, indicating a reassessment by analysts regarding the company's earnings outlook [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for Molson Coors is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -1.53%. This suggests a bearish sentiment among analysts regarding the company's earnings prospects [12]. - The stock currently holds a Zacks Rank of 4, which complicates the prediction of an earnings beat [12]. Historical Performance - In the last reported quarter, Molson Coors was expected to post earnings of $1.83 per share but exceeded expectations with actual earnings of $2.05, resulting in a surprise of +12.02%. Over the past four quarters, the company has beaten consensus EPS estimates three times [13][14]. Market Reaction Factors - An earnings beat or miss may not solely dictate stock price movements, as other factors can influence investor sentiment. Stocks may decline despite an earnings beat or rise despite a miss due to unforeseen catalysts [15]. - It is suggested that focusing on stocks expected to beat earnings expectations can enhance investment success, highlighting the importance of monitoring Earnings ESP and Zacks Rank prior to earnings releases [16].

Core Viewpoint - Cava Group (CAVA) is anticipated to report a year-over-year decline in earnings despite an increase in revenues for the quarter ending September 2025, with the consensus outlook indicating a significant impact on its near-term stock price based on actual results compared to estimates [1][2]. Earnings Expectations - The upcoming earnings report is scheduled for November 4, and if the results exceed expectations, the stock may rise; conversely, a miss could lead to a decline [2]. - The consensus estimate for Cava's quarterly earnings is projected at $0.13 per share, reflecting a year-over-year decrease of 13.3%, while revenues are expected to reach $293.31 million, marking a 20.3% increase from the previous year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 18.02%, indicating a collective reassessment by analysts regarding the company's earnings prospects [4]. - The Most Accurate Estimate for Cava is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -5.77%, coupled with a Zacks Rank of 4, suggesting a challenging outlook for beating the consensus EPS estimate [11]. Earnings Surprise History - In the last reported quarter, Cava was expected to post earnings of $0.13 per share but actually delivered $0.16, resulting in a positive surprise of 23.08% [12]. - Over the past four quarters, Cava has surpassed consensus EPS estimates three times [13]. Industry Comparison - Shake Shack (SHAK), another player in the Zacks Retail - Restaurants industry, is expected to report earnings of $0.31 per share for the same quarter, indicating a year-over-year increase of 24%, with revenues projected at $363.46 million, up 14.7% from the previous year [17][18]. - Shake Shack's consensus EPS estimate has been revised up by 1.6% over the last 30 days, but it also has an Earnings ESP of -4.9% and a Zacks Rank of 4, making it difficult to predict a beat on the consensus EPS estimate [19].